Benitec Biopharma Inc - Company Profile
Powered by 
All the data and insights you need on Benitec Biopharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Benitec Biopharma Inc Strategy Report
- Understand Benitec Biopharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Benitec Biopharma Inc (Benitec) is a development stage biotechnology company that focus on development of novel genetic medicines for treatment of chronic and life threatening diseases. The company uses DNA-directed RNA interference (ddRNAi) technology for treatments of serious human diseases including oculopharyngeal muscular dystrophy (OPMD) and chronic hepatitis B. The company operates through one reportable segment. Its proprietary DNA directed RNA interference technology combines RNA interface with viral vectors and produce long-term silencing of disease-causing genes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer